Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 376
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | ||
| NCT02334527 | Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy | ||
| NCT04700527 | The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study | ||
| NCT05828927 | enCompass Carolina: A Social Support and Coaching Program for Cancer Caregivers | ||
| NCT00320073 | Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors | ||
| NCT00005827 | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | ||
| NCT06480773 | Kaposi Sarcoma Chemotherapy and Research (KS-CARE) | ||
| NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | ||
| NCT04656873 | Immuno-Oncology Database and Bioregistry | ||
| NCT00467727 | Visibility of Lesion Characteristics With Phase Contrast Mammography | ||
| NCT00577694 | Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT04292860 | Reverse Axillary Mapping in Breast Radiation Treatment Planning | ||
| NCT03594162 | Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch | ||
| NCT00520091 | Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer | ||
| NCT01412229 | Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT01751529 | Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer | ||
| NCT05440929 | Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians | ||
| NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | ||
| NCT06674889 | Rehabilitation Outcomes Study | ||
| NCT03418792 | Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx | ||
| NCT06702592 | Virtual Testis Cancer Lay Support and Survivorship Aim 2 | ||
| NCT02276560 | Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC | ||
| NCT05744960 | Impact of Financial Incentives | ||
| NCT04342260 | Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes | ||
| NCT06848491 | Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors | ||
| NCT06519994 | Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya | ||
| NCT04223765 | Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. | ||
| NCT06263582 | Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya | ||
| NCT03264131 | BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma | ||
| NCT02075320 | Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules | ||
| NCT00225420 | Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer | ||
| NCT02139774 | Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer | ||
| NCT03176082 | Mailed Reminders Plus Fecal Immunochemical Testing | ||
| NCT00519831 | Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC | ||
| NCT05630131 | ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy | ||
| NCT03785782 | ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer | ||
| NCT02191982 | The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | ||
| NCT05592665 | PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology | ||
| NCT06618274 | Effectiveness of Central Oncology Navigation and the Use of an ORN | ||
| NCT05366166 | Pembrolizumab Plus Olaparib in LA-HNSCC | ||
| NCT05743426 | Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies | ||
| NCT00233974 | Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery | ||
| NCT04743674 | Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment | ||
| NCT02564120 | North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | ||
| NCT01262820 | Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab | ||
| NCT05498220 | Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma | ||
| NCT01685762 | Metformin for the Treatment of Endometrial Hyperplasia | ||
| NCT00003392 | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | ||
| NCT04564989 | Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC |
